Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker
Prediction models are increasingly used to complement clinical reasoning and decision making in modern medicine in general, and in the cardiovascular domain in particular. Developed models first and foremost need to provide accurate and (internally and externally) validated estimates of probabilitie...
Main Authors: | Moons, K, Kengne, A, Woodward, M, Royston, P, Vergouwe, Y, Altman, D, Grobbee, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker.
by: Moons, K, et al.
Published: (2012) -
Risk prediction models: II. External validation, model updating, and impact assessment.
by: Moons, K, et al.
Published: (2012) -
Risk prediction models: II. External validation, model updating, and impact assessment
by: Moons, K, et al.
Published: (2012) -
Development and validation of a prediction model with missing predictor data: a practical approach.
by: Vergouwe, Y, et al.
Published: (2010) -
Prognosis and prognostic research: what, why, and how?
by: Moons, K, et al.
Published: (2009)